288 related articles for article (PubMed ID: 25200076)
1. Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer.
Moquet-Torcy G; Tolza C; Piechaczyk M; Jariel-Encontre I
Nucleic Acids Res; 2014; 42(17):11011-24. PubMed ID: 25200076
[TBL] [Abstract][Full Text] [Related]
2. Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers.
Bejjani F; Tolza C; Boulanger M; Downes D; Romero R; Maqbool MA; Zine El Aabidine A; Andrau JC; Lebre S; Brehelin L; Parrinello H; Rohmer M; Kaoma T; Vallar L; Hughes JR; Zibara K; Lecellier CH; Piechaczyk M; Jariel-Encontre I
Nucleic Acids Res; 2021 Mar; 49(5):2488-2508. PubMed ID: 33533919
[TBL] [Abstract][Full Text] [Related]
3. Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells.
Ndlovu MN; Van Lint C; Van Wesemael K; Callebert P; Chalbos D; Haegeman G; Vanden Berghe W
Mol Cell Biol; 2009 Oct; 29(20):5488-504. PubMed ID: 19687301
[TBL] [Abstract][Full Text] [Related]
4. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
6. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
[TBL] [Abstract][Full Text] [Related]
7. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
[TBL] [Abstract][Full Text] [Related]
8. Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.
Hu Q; Lu YY; Noh H; Hong S; Dong Z; Ding HF; Su SB; Huang S
Oncogene; 2013 Aug; 32(34):3933-43. PubMed ID: 22986534
[TBL] [Abstract][Full Text] [Related]
9. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
11. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.
Tolza C; Bejjani F; Evanno E; Mahfoud S; Moquet-Torcy G; Gostan T; Maqbool MA; Kirsh O; Piechaczyk M; Jariel-Encontre I
Mol Cancer Res; 2019 Oct; 17(10):1999-2014. PubMed ID: 31300541
[TBL] [Abstract][Full Text] [Related]
12. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
13. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
[TBL] [Abstract][Full Text] [Related]
14. Expression of activator protein-1 (AP-1) family members in breast cancer.
Kharman-Biz A; Gao H; Ghiasvand R; Zhao C; Zendehdel K; Dahlman-Wright K
BMC Cancer; 2013 Sep; 13():441. PubMed ID: 24073962
[TBL] [Abstract][Full Text] [Related]
15. Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm.
Motrich RD; Castro GM; Caputto BL
PLoS One; 2013; 8(1):e53211. PubMed ID: 23301044
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.
D'Orazio D; Besser D; Marksitzer R; Kunz C; Hume DA; Kiefer B; Nagamine Y
Gene; 1997 Nov; 201(1-2):179-87. PubMed ID: 9409785
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
18. Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.
Desmet CJ; Gallenne T; Prieur A; Reyal F; Visser NL; Wittner BS; Smit MA; Geiger TR; Laoukili J; Iskit S; Rodenko B; Zwart W; Evers B; Horlings H; Ajouaou A; Zevenhoven J; van Vliet M; Ramaswamy S; Wessels LF; Peeper DS
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5139-44. PubMed ID: 23483055
[TBL] [Abstract][Full Text] [Related]
19. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
